Bid Price | 0.05p | High Price | 0.06p |
---|
Ask Price | 0.06p | Low Price | 0.05p |
---|
Open Price | 0.05p | Spread | 12.73% |
---|
Prev Close | 0.05p | Volume | 4,045,338 |
---|
Nuformix PLC Historic Prices
Date | Open | High | Low | Close | Volume |
---|
Nov 18, 2024 | 0.05 | 0.05 | 0.05 | 0.05 | 3,566,516 |
Nov 15, 2024 | 0.05 | 0.05 | 0.04 | 0.05 | 1,849,634 |
Nov 14, 2024 | 0.05 | 0.06 | 0.05 | 0.05 | 7,080,920 |
Nov 13, 2024 | 0.04 | 0.05 | 0.04 | 0.05 | 2,690,195 |
Nov 12, 2024 | 0.06 | 0.06 | 0.05 | 0.05 | 18,662,568 |
More Nuformix PLC Historic Prices >Nuformix PLC Information
Name | Nuformix PLC | Index | |
---|
ISIN | GB00BYW79Y38 | Epic | NFX |
---|
Type | Equity | Currency | GBX |
---|
Record Status | Active | Trading Segment | SET3 |
---|
Industry | Biotechnology | Sector | Healthcare |
---|
EMS | 1,500,000 | Trading Status | Post Trading |
---|
Shares in Issue | 819.31 m | Prev Close | 0.05p |
---|
PE Ratio | | Market Cap | £409,654.68 |
---|
Div Yield | 0 | Div per Share | £NaN |
---|
EPS | £-0.00 | Div Cover | NaN |
---|
PEG | n/a | EPS Growth (%) | 0.00 |
---|
ROCE | n/a | DPS Growth (%) | 0 |
---|
Current Ratio | 1.115864 | Quick Ratio | 0.849394 |
---|
Nuformix PLC Director Deals
Declared | Type | Director | Pos. | Volume / Price | Value |
---|
05/11/24 | PLAC | Daniel Gooding | RES | 12,000,000 @ £0.00 | £6,000.00 |
05/11/24 | PLAC | Madeleine Kennedy | NED | 22,000,000 @ £0.00 | £11,000.00 |
05/11/24 | PLAC | Julian Gilbert | NED | 22,000,000 @ £0.00 | £11,000.00 |
10/01/22 | BUY | Alastair Riddell | RES | 400,000 @ £0.01 | £4,700.00 |
16/09/21 | BUY | Alastair Riddell | RES | 350,000 @ £0.01 | £4,725.00 |
30/03/21 | PLAC | Karl Keegan | RES | 250,000 @ £0.02 | £5,000.00 |
30/03/21 | PLAC | Madeleine Kennedy | NED | 250,000 @ £0.02 | £5,000.00 |
30/03/21 | PLAC | Julian Gilbert | NED | 250,000 @ £0.02 | £5,000.00 |
30/03/21 | PLAC | Anne Brindley | RES | 500,000 @ £0.02 | £10,000.00 |
05/02/20 | SELL | David Tapolczay | RES | 650,000 @ £0.09 | £56,550.00 |
More Nuformix PLC Director Deals >Nuformix PLC News